John V. Balen, Director at Cardlytics, Inc. (CDLX), bought 3,000 shares at $28.35 ($88K) on 2022-05-09, disclosed to the SEC on 2022-05-10.
Open-market purchase of $88k CDLX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.34 | 100 | $3K | 3.2% |
| 2 | $28.35 | 300 | $9K | 9.7% |
| 3 | $28.35 | 600 | $17K | 19.4% |
| 4 | $29.48 | 100 | $3K | 3.4% |
| 5 | $29.52 | 1,000 | $30K | 33.7% |
| 6 | $29.70 | 900 |
| $27K |
| 30.5% |
| Total | $29.18 avg | 3,000 | $88K | 100% |
| Filing → |
| CDLX | BUY | 2022-05-31 | $137K | — | Filing → |
| CDLX | BUY | 2021-08-31 | $90K | — | Filing → |
| CDLX | BUY | 2021-08-23 | $160K | — | Filing → |